Drawing for SCORPION

USPTO serial 75740293

SCORPION

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
LEIPZIG, MARC J
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SCORPION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001high avidity diagnostic preparations in the nature of binding proteins for scientific or research use in the medical, veterinary and environmental fieldsACTIVE
005high avidity diagnostic preparations in the nature of binding proteins for clinical or medical laboratory use in the medical, veterinary and environmental fields; high avidity binding proteins for use in the treatment or detection of viral, bacterial, fungal, helminth, mycoplasma, rickettsial, chlamydial or protozoan infections; high avidity binding proteins for use in the treatment or detection of diseases and conditions caused by natural immune hormones namely rheumatoid arthritis, Crohn's disease, osteoporosis, type 2 diabetes, diabetic retinopathy, congestive heart disease, lupus, scleroderma, psoriasis, aczema, ulcerative colitis, chronic fatigue syndrome, asthma, immediate and delayed hypersensitivity reactions, allergies, disorders of thrombosis and coagulation, atherosclerosis, alzheimers disease, multiple sclerosis and demyelination diseases, myasthenia gravis and diseases of neuromuscular junctions, diarrhea, fever, shock, obesity, transplant graft rejection; high avidity binding proteins for use in the treatment of detection of cancers, namely carcinomas, sarcomas, and leukemia; high avidity binding proteins for the use in blocking the activity of natural antibodies or lymphocytes that cause autoimmune diseases, namely type 1 diabetes, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, autoimmune hemolytic anemia and autoimmune thrombocytopenic purpuraACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 17, 2004MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 17, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 21, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2003CFITCASE FILE IN TICRS
Oct 29, 2001CNSLLETTER OF SUSPENSION MAILED
Jun 12, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2001CNSLLETTER OF SUSPENSION MAILED
Aug 31, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2000CNSLLETTER OF SUSPENSION MAILED
Jan 10, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 1999DOCKASSIGNED TO EXAMINER
Sep 17, 1999DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance